VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 374 filers reported holding VANECK VECTORS ETF TR in Q2 2017. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $16,810,223 | -9.1% | 624,683 | +1.7% | 0.01% | 0.0% |
Q2 2023 | $18,487,916 | -48.8% | 614,012 | -45.0% | 0.01% | -52.9% |
Q1 2023 | $36,094,047 | +13.5% | 1,115,736 | +0.5% | 0.02% | +6.2% |
Q4 2022 | $31,804,639 | +111.7% | 1,109,722 | +78.2% | 0.02% | +77.8% |
Q3 2022 | $15,023,000 | -20.6% | 622,842 | -9.8% | 0.01% | -18.2% |
Q2 2022 | $18,915,000 | -36.5% | 690,822 | -11.1% | 0.01% | -26.7% |
Q1 2022 | $29,803,000 | +87.1% | 777,120 | +56.3% | 0.02% | +87.5% |
Q4 2021 | $15,929,000 | -2.2% | 497,309 | -10.0% | 0.01% | -11.1% |
Q3 2021 | $16,282,000 | -5.2% | 552,495 | +9.3% | 0.01% | -10.0% |
Q2 2021 | $17,169,000 | +33.0% | 505,264 | +27.2% | 0.01% | +25.0% |
Q1 2021 | $12,913,000 | -48.0% | 397,331 | -42.3% | 0.01% | -57.9% |
Q4 2020 | $24,809,000 | -23.2% | 688,750 | -16.5% | 0.02% | -34.5% |
Q3 2020 | $32,291,000 | +3.4% | 824,590 | -3.2% | 0.03% | -6.5% |
Q2 2020 | $31,241,000 | +378.3% | 851,711 | +200.5% | 0.03% | +287.5% |
Q1 2020 | $6,531,000 | -27.0% | 283,472 | -7.2% | 0.01% | -11.1% |
Q4 2019 | $8,948,000 | -27.3% | 305,594 | -33.7% | 0.01% | -30.8% |
Q3 2019 | $12,314,000 | +30.3% | 461,026 | +24.7% | 0.01% | +8.3% |
Q2 2019 | $9,452,000 | -17.4% | 369,816 | -27.6% | 0.01% | -25.0% |
Q1 2019 | $11,447,000 | +18.6% | 510,593 | +11.6% | 0.02% | +6.7% |
Q4 2018 | $9,649,000 | +431.6% | 457,534 | +366.9% | 0.02% | +400.0% |
Q3 2018 | $1,815,000 | -0.8% | 97,994 | +19.4% | 0.00% | -25.0% |
Q2 2018 | $1,830,000 | +56.1% | 82,078 | +56.8% | 0.00% | +33.3% |
Q1 2018 | $1,172,000 | -49.4% | 52,345 | -47.5% | 0.00% | -40.0% |
Q4 2017 | $2,318,000 | -41.2% | 99,719 | -41.9% | 0.01% | -44.4% |
Q3 2017 | $3,939,000 | +96.1% | 171,578 | +88.6% | 0.01% | +50.0% |
Q2 2017 | $2,009,000 | +1.1% | 90,974 | +4.5% | 0.01% | 0.0% |
Q1 2017 | $1,987,000 | +12.6% | 87,086 | +3.2% | 0.01% | 0.0% |
Q4 2016 | $1,764,000 | -79.9% | 84,353 | -74.6% | 0.01% | -82.4% |
Q3 2016 | $8,774,000 | -58.9% | 331,953 | -56.9% | 0.03% | -60.0% |
Q2 2016 | $21,351,000 | – | 770,524 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |